Use the links below to learn about the routing, review and negotiation processes for various types of agreements. In general, the Principal Investigator and department administrator are responsible for defining and agreeing to the scope of work and for ensuring that the agreed-upon budget covers the cost of the project and includes the appropriate indirect cost rate. The Office of Research and Development is responsible for reviewing and, if necessary, negotiating the agreement terms and conditions, to ensure that they do not conflict with applicable regulations, State law or University policy. After review of the proposed project, Office of Research and Development will draw up an appropriate agreement or will review the other party’s offered agreement. An authorized institutional official in Office of Research and Development will sign the agreement. The Principal Investigator is not authorized to commit the institution – the PI may only sign to indicate commitment to a project or acknowledgment of agreement terms and conditions. Corporate-sponsored clinical studies (1) that involve the testing of a drug or device and (2) where the protocol has been written by the company are negotiated by the Center for Clinical Trials. This includes studies for which UMB is a subcontractor, as well as "compassionate use" studies. Routing is required for all clinical study agreements.
Frequently Asked Question back to top | 
